HomeCompareUFFRF vs MRK

UFFRF vs MRK: Dividend Comparison 2026

UFFRF yields 1540.83% · MRK yields 2.81%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 UFFRF wins by $896500986.65M in total portfolio value
10 years
UFFRF
UFFRF
● Live price
1540.83%
Share price
$0.13
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$896500986.71M
Annual income
$795,004,282,156,840.80
Full UFFRF calculator →
MRK
Merck & Co. Inc.
● Live price
2.81%
Share price
$118.10
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$57.7K
Annual income
$10,113.78
Full MRK calculator →

Portfolio growth — UFFRF vs MRK

📍 UFFRF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodUFFRFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, UFFRF + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
UFFRF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

UFFRF
Annual income on $10K today (after 15% tax)
$130,970.72/yr
After 10yr DRIP, annual income (after tax)
$675,753,639,833,314.60/yr
MRK
Annual income on $10K today (after 15% tax)
$238.95/yr
After 10yr DRIP, annual income (after tax)
$8,596.71/yr
At 15% tax rate, UFFRF beats the other by $675,753,639,824,717.90/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of UFFRF + MRK for your $10,000?

UFFRF: 50%MRK: 50%
100% MRK50/50100% UFFRF
Portfolio after 10yr
$448250493.38M
Annual income
$397,502,141,083,477.25/yr
Blended yield
88.68%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

UFFRF
No analyst data
MRK
Analyst Ratings
24
Buy
12
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+8.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

UFFRF buys
0
MRK buys
8
PoliticianChamberTickerTypeAmountDate
Josh Gottheimer🏢 House$MRK▲ Buy$1,001 - $15,0002026-02-04
Michael McCaul🏢 House$MRK▼ Sell$15,001 - $50,0002026-01-13
Gilbert Cisneros🏢 House$MRK▲ Buy$1,001 - $15,0002025-12-19
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-12-18
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-11-13
Ro Khanna🏢 House$MRK▼ Sell$1,001 - $15,0002025-09-29
Val Hoyle🏢 House$MRK▼ Sell$1,001 - $15,0002025-09-23
Marjorie Taylor Greene🏢 House$MRK▲ Buy$1,001 - $15,0002025-08-28
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-08-14
Gilbert Cisneros🏢 House$MRK▲ Buy$1,001 - $15,0002025-08-05
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricUFFRFMRK
Forward yield1540.83%2.81%
Annual dividend / share$2.00$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%32.7%
Portfolio after 10y$896500986.71M$57.7K
Annual income after 10y$795,004,282,156,840.80$10,113.78
Total dividends collected$889131532.92M$29.8K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: UFFRF vs MRK ($10,000, DRIP)

YearUFFRF PortfolioUFFRF Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$164,783$154,083.20$11,213$373.04+$153.6KUFFRF
2$2,549,246$2,372,927.51$12,667$512.06+$2.54MUFFRF
3$37,036,010$34,308,317.10$14,439$708.14+$37.02MUFFRF
4$505,459,288$465,830,757.96$16,640$988.16+$505.44MUFFRF
5$6,482,481,979$5,941,640,540.28$19,432$1,394.07+$6482.46MUFFRF
6$78,152,281,291$71,216,025,573.85$23,057$1,992.90+$78152.26MUFFRF
7$886,029,179,996$802,406,239,013.85$27,889$2,894.79+$886029.15MUFFRF
8$9,449,968,682,448$8,501,917,459,852.98$34,518$4,286.29+$9449968.65MUFFRF
9$94,856,733,224,262$84,745,266,734,042.48$43,912$6,494.35+$94856733.18MUFFRF
10$896,500,986,706,801$795,004,282,156,840.80$57,714$10,113.78+$896500986.65MUFFRF

UFFRF vs MRK: Complete Analysis 2026

UFFRFStock

Unifin Financiera, S. A. B. de C. V. operates as a leasing company in Mexico. The company operates through Leases, Factoring, and Others Loans segments. It provides leasing facilities for motor vehicles, such as cars, trucks, helicopters, aircraft, and ships; and machinery and equipment, as well as the assets of various industries in the middle-sized enterprise sector. The company also offers liquidity and financial solutions to customers by acquiring or discounting accounts receivables; financing for the working capital needs and the purchase of other capital goods; and granting loans for the acquisition of new or used vehicles to individuals and legal entities. In addition, it is involved in obtaining loans; guaranteeing obligations; and issuing, subscribing, accepting, endorsing, selling, discounting, and pledging various types of credits, as well as acting as administrator for guarantee trusts. Further, the company provides damage and theft, mayor medical expenses, auto, home, civil liability, life, and surety bail bonds insurance products. Unifin Financiera, S. A. B. de C. V. was incorporated in 1993 and is based in Mexico City, Mexico.

Full UFFRF Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this UFFRF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

UFFRF vs SCHDUFFRF vs JEPIUFFRF vs OUFFRF vs KOUFFRF vs MAINUFFRF vs JNJUFFRF vs ABBVUFFRF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.